GOLDILOX-T Trademark

Trademark Overview


On Tuesday, June 21, 2016, a trademark application was filed for GOLDILOX-T with the United States Patent and Trademark Office. The USPTO has given the GOLDILOX-T trademark a serial number of 79193611. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 8, 2023. This trademark is owned by Cartherics Pty Ltd. The GOLDILOX-T trademark is filed in the Pharmaceutical Products category with the following description:

Biological preparations for medical purposes for the treatment of cancer; biological preparations for pharmaceutical purposes for the treatment of cancer; biological preparations for medical use in biotechnology for the treatment of cancer; biological products for medical use, namely, Cytotoxic T cells with antigen receptor (TCR) specific for cancer plus a chimeric antigen receptor (CAR) specific for another cancer antigen; biological substances for medical use, namely, Cytotoxic T cells with antigen receptor (TCR) specific for cancer plus a chimeric antigen receptor (CAR) specific for another cancer antigen; therapeutic biological products for medical use, namely, Cytotoxic T cells with antigen receptor (TCR) specific for cancer plus a chimeric antigen receptor (CAR) specific for another cancer antigen
goldilox-t

General Information


Serial Number79193611
Word MarkGOLDILOX-T
Filing DateTuesday, June 21, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 8, 2023
Registration Number5206909
Registration DateTuesday, May 23, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 7, 2017

Trademark Statements


Description of MarkThe mark consists of wording "GOLDI" appearing in a polygon followed by the wording "LOX-T" with a stylized head of a bear above this wording.
Goods and ServicesBiological preparations for medical purposes for the treatment of cancer; biological preparations for pharmaceutical purposes for the treatment of cancer; biological preparations for medical use in biotechnology for the treatment of cancer; biological products for medical use, namely, Cytotoxic T cells with antigen receptor (TCR) specific for cancer plus a chimeric antigen receptor (CAR) specific for another cancer antigen; biological substances for medical use, namely, Cytotoxic T cells with antigen receptor (TCR) specific for cancer plus a chimeric antigen receptor (CAR) specific for another cancer antigen; therapeutic biological products for medical use, namely, Cytotoxic T cells with antigen receptor (TCR) specific for cancer plus a chimeric antigen receptor (CAR) specific for another cancer antigen
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 8, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCartherics Pty Ltd
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAU

Party NameCartherics Pty Ltd
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAU

Party NameCartherics Pty Ltd
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAU

Trademark Events


Event DateEvent Description
Monday, October 31, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, October 17, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, October 18, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 18, 2016ASSIGNED TO EXAMINER
Saturday, October 22, 2016APPLICATION FILING RECEIPT MAILED
Sunday, October 30, 2016NON-FINAL ACTION WRITTEN
Tuesday, March 7, 2017PUBLISHED FOR OPPOSITION
Tuesday, March 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 23, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, November 1, 2016REFUSAL PROCESSED BY MPU
Tuesday, November 1, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, November 18, 2016REFUSAL PROCESSED BY IB
Friday, December 30, 2016NEW REPRESENTATIVE AT IB RECEIVED
Friday, January 20, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, January 20, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 21, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 30, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 15, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 23, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, October 6, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, March 22, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 22, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, August 24, 2017FINAL DISPOSITION PROCESSED
Thursday, August 24, 2017FINAL DISPOSITION NOTICE SENT TO IB
Thursday, October 18, 2018NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, March 22, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 23, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Monday, December 19, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, December 8, 2023CANCELLED SECTION 71
Tuesday, March 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, August 20, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sunday, September 8, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, August 20, 2024INVALIDATION PROCESSED
Friday, August 9, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED